Biotech Innovation Requires a Predictable...Modern biotechnology creates next generation therapies and cures, delivers value to patients and the economy, cuts greenhouse gas emissions, reduces reliance on fossil fuels, and generates higher crop … more ➔
Investors make commitment to net zero emis...There was unparalleled surprise in New York when a powerful alliance of UN-backed asset owners announced it will drive it’s portfolio companies to carbon neutrality by 2050. This could mean a fundamental … more ➔
We need predictive safety biomarkers Every year, drug developers lose billions of euros because of late-stage clinical or postmarking safety problems with drugs. A recently kicked-off IMI consortium now wants to qualify a set of safety … more ➔
IP Flash: Patent IneligibilityBy Ute Kilger, Patent Attorney, European Patent and Trade Mark Attorney, Boehmert & Boehmert Anwaltspartnerschaft mbB The US Supreme Court has mutilated US Patent law with the law of nature doctrine … more ➔
Healthier and sustainable food ingredients...As food producers are taking up current health and sustainability trends more and more, the next EFIB (30 September??2 October, 2019) will see a lot of technology providers and ingredient producers showcasing … more ➔
Patent Ineligibility InitiativeBy Ute Kilger, Patent Attorney, European Patent and Trade Mark Attorney, Boehmert & Boehmert Anwaltspartnerschaft mbB The Life Science Industry needs a strong, predictable, reliable patent system … more ➔
Emergency on planet AMR: a vital pipeline... The recently released IACG report testifies that the antimicrobial resistance (AMR) problem is now receiving some echo at the political level. Literature exploring ways to fix the acknowledged market … more ➔
Functional sugars made by biotech for ever... Rare functional sugars provide huge market opportunities. European Biotechnology spoke with Stefan Jennewein, Founder and CEO of Jennewein Biotechnologies, about the company’s strategy and its latest … more ➔
Lessons from a former poster child With partner Indivior exchanging a late-stage addiction programme for early-stage alternatives, 2019 did not start exceptionally well for Addex Therapeutics. But, the Swiss drug developer has shown … more ➔
A national bioeconomy strategy for Austria Within the record time of nine months, the Austrian government, together with experts of the Austrian Bioeconomy plattform and the sustainability think tank Denkstatt, has worked out a national bioeconomy … more ➔
